J 2022

Contrast-induced acute kidney injury and its contemporary prevention

SŮVA, Marek, Petr KALA, Martin POLOCZEK, Jan KAŇOVSKÝ, Roman ŠTÍPAL et. al.

Základní údaje

Originální název

Contrast-induced acute kidney injury and its contemporary prevention

Autoři

SŮVA, Marek (203 Česká republika, domácí), Petr KALA (203 Česká republika, garant, domácí), Martin POLOCZEK (203 Česká republika, domácí), Jan KAŇOVSKÝ (203 Česká republika, domácí), Roman ŠTÍPAL (203 Česká republika, domácí), Martin RADVAN (203 Česká republika, domácí), Jiří HLÁSENSKÝ (203 Česká republika, domácí), Martin HUDEC (203 Česká republika, domácí), Vojtěch BRÁZDIL (203 Česká republika, domácí) a Jitka ŘEHOŘOVÁ (203 Česká republika)

Vydání

Frontiers in Cardiovascular Medicine, Lausanne, Frontiers, 2022, 2297-055X

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30201 Cardiac and Cardiovascular systems

Stát vydavatele

Švýcarsko

Utajení

není předmětem státního či obchodního tajemství

Odkazy

Impakt faktor

Impact factor: 3.600

Kód RIV

RIV/00216224:14110/22:00128215

Organizační jednotka

Lékařská fakulta

UT WoS

000899788400001

Klíčová slova anglicky

PCI; nephrotoxicity; acute kidney injury; contrast-induced acute kidney injury; chronic renal insufficiency; prevention

Štítky

Příznaky

Mezinárodní význam, Recenzováno
Změněno: 23. 1. 2023 10:38, Mgr. Tereza Miškechová

Anotace

V originále

The complexity and application range of interventional and diagnostic procedures using contrast media (CM) have recently increased. This allows more patients to undergo procedures that involve CM administration. However, the intrinsic CM toxicity leads to the risk of contrast-induced acute kidney injury (CI-AKI). At present, effective therapy of CI-AKI is rather limited. Effective prevention of CI-AKI therefore becomes crucially important. This review presents an in-depth discussion of CI-AKI incidence, pathogenesis, risk prediction, current preventive strategies, and novel treatment possibilities. The review also discusses the difference between CI-AKI incidence following intraarterial and intravenous CM administration. Factors contributing to the development of CI-AKI are considered in conjunction with the mechanism of acute kidney damage. The need for ultimate risk estimation and the prediction of CI-AKI is stressed. Possibilities of CI-AKI prevention is evaluated within the spectrum of existing preventive measures aimed at reducing kidney injury. In particular, the review discusses intravenous hydration regimes and pre-treatment with statins and N-acetylcysteine. The review further focuses on emerging alternative imaging technologies, alternative intravascular diagnostic and interventional procedures, and new methods for intravenous hydration guidance; it discusses the applicability of those techniques in complex procedures and their feasibility in current practise. We put emphasis on contemporary interventional cardiology imaging methods, with a brief discussion of CI-AKI in non-vascular and non-cardiologic imaging and interventional studies.